Related Experiment Videos
Gene therapy for malignant liver disease
Leonhard Mohr1, Michael Geissler, Hubert E Blum
1Department of Medicine II, University Hospital Freiburg, Hugstetter Strasse 55, D-79106 Freiburg, Germany. mohrl@sun11.ukl.uni-freiburg.de
Abstract:
For most patients with advanced or multifocal hepatocellular carcinoma (HCC) or with metastatic malignant liver disease treatment options are limited, resulting in a poor prognosis. Novel therapeutic strategies such as gene therapy are therefore urgently required. Gene therapeutic approaches use gene delivery systems (vectors) to introduce DNA constructs as therapeutic agents into living cells. Antitumour strategies include the reintroduction of tumour suppressor genes into tumour cells, the expression of foreign enzymes to render tumours susceptible to treatment with chemotherapeutic agents and the enhancement of tumour immunogenicity by expressing immunomodulatory genes or by genetic vaccination with tumour antigens. Furthermore, gene therapy may be also used for anti-angiogenesis to reduce tumour growth and metastatic potential. Other novel approaches aim at the development of genetically altered replication competent viruses, which selectively replicate in tumour cells inducing cell lysis. Although most clinical trials of antitumour gene therapy so far have failed to induce strong therapeutic effects, further improvement of antitumour gene therapy may finally result in potent clinical treatment options for patients with malignant liver tumours.
Insights
Gene therapy offers novel treatment strategies for advanced liver cancer (hepatocellular carcinoma) and metastatic liver disease. While current trials show limited effects, ongoing improvements in gene delivery and therapeutic approaches hold promise for future clinical applications.
Area of Science:
- Oncology
- Hepatology
- Gene Therapy
Background:
- Limited treatment options and poor prognosis for advanced/multifocal hepatocellular carcinoma (HCC) and metastatic liver disease.
- Urgent need for novel therapeutic strategies, including gene therapy, for malignant liver tumors.
Purpose of the Study:
- To review current gene therapy approaches for treating liver cancer.
- To highlight the potential of gene therapy in improving outcomes for patients with advanced liver malignancies.
Main Methods:
- Gene delivery systems (vectors) introduce therapeutic DNA constructs into cells.
- Strategies include reintroducing tumor suppressor genes, expressing foreign enzymes, enhancing immunogenicity, and anti-angiogenesis.
- Development of oncolytic viruses that selectively replicate in tumor cells.
Main Results:
- Current clinical trials of antitumour gene therapy have not yet demonstrated strong therapeutic effects.
- Gene therapy offers diverse mechanisms to combat liver tumors, including direct cell killing and inhibiting tumor growth.
Conclusions:
- Despite current limitations, advancements in gene therapy hold potential for future effective clinical treatments for liver cancer.
- Further research and development are crucial to realize the full therapeutic potential of gene therapy in oncology.